These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 26077689)
1. Soluble ST2 and troponin I combination: Useful biomarker for predicting development of stress cardiomyopathy in patients admitted to the medical intensive care unit. Yang HS; Kim HJ; Shim HJ; Kim SJ; Hur M; Di Somma S; Heart Lung; 2015; 44(4):282-8. PubMed ID: 26077689 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery. Yang HS; Hur M; Yi A; Kim H; Kim J Ann Lab Med; 2018 May; 38(3):204-211. PubMed ID: 29401554 [TBL] [Abstract][Full Text] [Related]
3. [Predictive value of early detection of hs-cTnI and sST2 for secondary cardiac damage in severe acute organophosphorus pesticide poisoning]. Liu XT; Wang L; Chen J; Qi HN; Ma GY Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Apr; 38(4):241-245. PubMed ID: 32447883 [No Abstract] [Full Text] [Related]
4. Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain. Marino R; Magrini L; Orsini F; Russo V; Cardelli P; Salerno G; Hur M; Di Somma S; Ann Lab Med; 2017 Mar; 37(2):137-146. PubMed ID: 28029000 [TBL] [Abstract][Full Text] [Related]
5. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality. Klouche K; Pommet S; Amigues L; Bargnoux AS; Dupuy AM; Machado S; Serveaux-Delous M; Morena M; Jonquet O; Cristol JP J Intensive Care Med; 2014; 29(4):229-37. PubMed ID: 23753226 [TBL] [Abstract][Full Text] [Related]
6. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency. Kim MS; Jeong TD; Han SB; Min WK; Kim JJ J Korean Med Sci; 2015 May; 30(5):569-75. PubMed ID: 25931787 [TBL] [Abstract][Full Text] [Related]
7. Serum Cardiac Biomarkers in Asymptomatic Hemodialysis Patients: Role of Soluble Suppression of Tumorigenicity-2. Mancianti N; Maresca B; Palladino M; Salerno G; Cardelli P; Menè P; Barberi S Blood Purif; 2022; 51(2):155-162. PubMed ID: 33910194 [TBL] [Abstract][Full Text] [Related]
8. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) study. Dieplinger B; Egger M; Koehler W; Firlinger F; Poelz W; Lenz K; Haltmayer M; Mueller T Clin Chim Acta; 2012 Mar; 413(5-6):587-93. PubMed ID: 22155704 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients. Dieplinger B; Egger M; Leitner I; Firlinger F; Poelz W; Lenz K; Haltmayer M; Mueller T J Crit Care; 2016 Aug; 34():38-45. PubMed ID: 27288608 [TBL] [Abstract][Full Text] [Related]
11. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T. Dispenzieri A; Gertz MA; Saenger A; Kumar SK; Lacy MQ; Buadi FK; Dingli D; Leung N; Zeldenrust S; Hayman SR; Kapoor P; Grogan M; Hwa L; Russell SJ; Go RS; Rajkumar SV; Kyle RA; Jaffe A Am J Hematol; 2015 Jun; 90(6):524-8. PubMed ID: 25753178 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study. Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850 [TBL] [Abstract][Full Text] [Related]
13. High Serum sTREM-1 Correlates With Myocardial Dysfunction and Predicts Prognosis in Septic Patients. Li Z; Zhang E; Hu Y; Liu Y; Chen B Am J Med Sci; 2016 Jun; 351(6):555-62. PubMed ID: 27238916 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144 [TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Friões F; Lourenço P; Laszczynska O; Almeida PB; Guimarães JT; Januzzi JL; Azevedo A; Bettencourt P Clin Res Cardiol; 2015 Jun; 104(6):491-9. PubMed ID: 25586507 [TBL] [Abstract][Full Text] [Related]
17. Moderate elevations of high-sensitivity cardiac troponin I and B-type natriuretic peptide in chronic hemodialysis patients are associated with mortality. Geerse DA; van Berkel M; Vogels S; Kooman JP; Konings CJ; Scharnhorst V Clin Chem Lab Med; 2013 Jun; 51(6):1321-8. PubMed ID: 23241607 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure. Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817 [TBL] [Abstract][Full Text] [Related]
19. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy. Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913 [TBL] [Abstract][Full Text] [Related]
20. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction. Zhang K; Zhang XC; Mi YH; Liu J Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]